Remove 2017 Remove Communication Remove Vaccines
article thumbnail

How automation can help to address supply chain challenges in pharma

pharmaphorum

Supply chain challenges take many forms in pharma – from capacity issues, to managing excess safety stock, and ensuring accurate supplier communication. Better communication with traceable data. Automated systems allow suppliers to maintain complete traceability over their processes and communicate in the most effective way possible.

article thumbnail

Why pharma needs a revolution in culture

pharmaphorum

He was referring to his business’ share of misconduct related fines that, between 2009 and 2017, topped $342 billion across the US and Europe. It’s killing us.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Streamlining Postapproval Submissions Using ICH Q12 & SCDM

ISPE

BioProcess International 15 (September 2017):24–47. Ideally, data and information from multiple regions could be submitted simultaneously, available for all regulatory bodies to access and review as required, thereby allowing regulators to communicate with each other and see previous questions and decisions of other regulatory bodies.

article thumbnail

OVID Health appoints high-profile leaders as senior counsel

pharmaphorum

Independent communications agency OVID Health has appointed Niall Dickson, professor David Salisbury and Athena Lamnisos as senior counsel, providing strategic advice and thought leadership across several projects involving healthcare and pharma clients. He was awarded a CBE for patient safety in 2017.

article thumbnail

Message from the Chair an Exciting Year

ISPE

Reintroducing the liaison role of International Board members with individual Chapters and Affiliates has given us direct lines of communication to the mutual benefit of the International Board and the local groups. Tim Howard, who was Chair of the International Board from 2017–2018, helped by moderating the sessions. Thank you, Tim!

article thumbnail

Patient centricity and the changing pharmaceutical vista

pharmaphorum

“We’ve almost got an opportunity to take it to the next level now, because we saw this with the collaboration with the COVID vaccine development and roll-out of the vaccination programme. Having the ability of these groups to be able to communicate directly with patients is tremendous.”

article thumbnail

Accommodating Multiple Modalities in the Same Facility

ISPE

ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Viral antigen vaccines. For example: Live vaccine manufacturing. Complete Data Gathering.